Excellent
Mostly Aligned
Patient Risk:
Low
Summary
The evaluated claim exactly matches the FDA-approved indication wording in the provided label excerpt, including patient population (adults) and intended use (visualization aid for ureteral integrity after specified surgical procedure types).
Category Scores
Accurate Statements
BLUDIGO is indicated for use as a visualization aid in the cystoscopic assessment of the integrity of the ureters in adults following urological and gynecological open, robotic, or endoscopic surgical procedures.
Section 1 INDICATIONS AND USAGE: “BLUDIGO is indicated for use as a visualization aid in the cystoscopic assessment of the integrity of the ureters in adults following urological and gynecological open, robotic, or endoscopic surgical procedures.”
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
No safety-relevant dosing, contraindication, warning, or adverse reaction claims were evaluated; only the on-label indication for adults was assessed.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Suggested Improvement